Consultations
Search open and closed consultations on the way we regulate medicines, medical devices and biologicals.
- You can also find, read and respond to recent consultations, submissions and decisions at the TGA Consultation hub.
- Find more scheduling consultations on the Poisons Standard in our Interim decisions.
- Archived consultations and reviews can be viewed on the National Library of Australia Trove site.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Scheduling (national classification system) (79)
- Therapeutic goods regulation (18)
- Prescription medicines (16)
- Over the counter (OTC) medicines (15)
- Advisory bodies and committees (12)
- Complementary medicines (12)
- Legislation (12)
- Non-prescription medicines (11)
- Listed medicines (9)
- Labelling and packaging (6)
- Manufacturing (6)
- In Vitro Diagnostic medical devices (IVDs) (4)
- Medical devices safety (4)
- Advertising (3)
- Australian Register of Therapeutic Goods (ARTG) (3)
- Biological medicines (3)
- Medicine safety (3)
- Sunscreens (3)
- Fees and payments (2)
- Import and export (2)
- Safety (2)
- Shortages (2)
- Artificial Intelligence (AI) (1)
- Assessed listed medicines (1)
- Blood and blood components (1)
- Clinical trials (1)
- Disinfectants/Sterilants (1)
- Medicinal cannabis hub (1)
- Registered complementary medicines (1)
- Unique Device Identification (UDI) hub (1)
- Vaping hub (1)
Use the filters or search function to help find relevant consultations.
Search
254 result(s) found, displaying 1 to 25
-
ConsultationWe are seeking feedback on whether we should adopt 3 international scientific guidelines.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS)
-
ConsultationIn accordance with regulation 42ZCZK of the Therapeutic Goods Regulations 1990, the Secretary invites public submissions on scheduling proposals referred to the June 2025 meetings of the Advisory Committees on Medicines and Chemicals Scheduling.
-
ConsultationWe are seeking stakeholders’ feedback on proposed changes to the IVD medical device classifications and definitions.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the
Advisory Committee on Medicines Scheduling (ACMS), or a joint meeting of the ACMS and Advisory Committee on Chemicals Scheduling (ACCS) -
ConsultationWe are seeking feedback on two new guidance documents developed as part of the proposed new risk-based application audit framework.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Chemicals Scheduling (ACCS) and joint meeting of the Advisory Committee on Medicines Scheduling (ACMS) and ACCS.
-
ConsultationWe are seeking feedback on whether 19 international scientific guidelines should be adopted.
-
ConsultationWe are seeking feedback on proposed improvements to TGA’s regulatory framework for medicine shortages and discontinuations in Australia.
-
ConsultationHave your say on the proposed changes to the Australian Essential Principles for Safety and Performance of medical devices (Essential Principles). Closing date has been extended from 16 October to 13 November 2024.
-
ConsultationThe TGA is seeking feedback on proposed changes to the regulation of assistive technologies.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), meeting of the Advisory Committee on Chemicals Scheduling (ACCS), or a joint meeting of these two committees.
-
ConsultationThis consultation paper seeks feedback on proposals identified for mitigating risks and leveraging opportunities associated with the use of AI models.
-
ConsultationThis consultation is for interim decisions made in relation to substances that were discussed at the JUNE 2024 meetings of the Advisory Committee on Medicines Scheduling (ACMS) and the Advisory Committee on Chemicals Scheduling (ACCS).
-
ConsultationWe are seeking feedback on draft guidance documentation 'Regulatory changes for medical devices containing medicinal substances or materials of animal, microbial, or recombinant origin - guidance on the new regulatory requirements and transition arrangements'.
-
ConsultationWe are seeking feedback on the proposed temporary labelling exemptions for paracetamol.
-
ConsultationThe TGA sought feedback from interested parties on proposed changes to the requirements of ingredients used in listed (low-risk) medicines.
-
ConsultationThe TGA is seeking feedback from interested parties on the proposed changes to replace the sunsetting TGO 70C with a new instrument
-
ConsultationHave your say on the need for additional clarity and transparency on the regulatory category of some boundary and combination products.
-
ConsultationHave your say on potential reforms to Part 5 of the Therapeutic Goods Regulations 1990.
-
ConsultationThe TGA is seeking feedback on a revised version of the guidance document ‘TGA Instructions for Disinfectant Testing’.
-
Consultation: Proposed exposure model for assessing the safety of sunscreen ingredients in Australia
ConsultationHave your say on best way to estimate sunscreen use in Australia. Your feedback will be used to calculate the safe concentration of sunscreen ingredients. -
ConsultationHave your say about proposed changes to address 3 medicine safety matters needing action, before we review labelling rules more broadly.
-
ConsultationWe are seeking your feedback on the updated draft Companion Diagnostics (CDx) Guidance document.
-
ConsultationWe are seeking feedback on proposed changes to the regulation of exempt medical devices and exempt Other Therapeutic Goods (OTGs).